Produktinformation
- 3,15-Dihydroxy-16,17-dimethoxytricyclo[12.3.1.1<sup>2,6</sup>]nonadeca-1(18),2,4,6(19),14,16-hexaen-9-one
- Tricyclo[12.3.1.1<sup>2,6</sup>]nonadeca-1(18),2,4,6(19),14,16-hexaen-9-one, 3,15-dihydroxy-16,17-dimethoxy-
- Tricyclo[12.3.1.1~2,6~]Nonadeca-1(18),2,4,6(19),14,16-Hexaen-9-One, 3,15-Dihydroxy-16,17-Dimethoxy-
- 3,15-Dihydroxy-16,17-dimethoxytricyclo[12.3.1.12,6]nonadeca-1(18),2,4,6(19),14,16-hexaen-9-one
- Tricyclo[12.3.1.12,6]nonadeca-1(18),2,4,6(19),14,16-hexaen-9-one, 3,15-dihydroxy-16,17-dimethoxy-
Myricanone is a synthetic curcumin analog that is used to treat bowel disease, skin cancer, and other conditions. It has been shown to inhibit protein target nitro (PTN), a key enzyme in the synthesis of proteins involved in inflammation and cancer. Myricanone also inhibits the growth of cancer cells by inhibiting their ability to divide and proliferate. Myricanone has been found to have anti-inflammatory effects, which may be due to its inhibition of cyclooxygenase 2 (COX-2) and prostaglandin E2 (PGE2). Myricanone has also been shown to have sodium-dependent glucose cotransporter 1 (SGLT1) activity. The compound causes mitochondrial membrane depolarization by inhibiting complex I of the electron transport chain.
Chemische Eigenschaften
Technische Anfrage zu: 3D-HBA49274 Myricanone
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
